Remove Exercise Remove Heart Failure Remove Pharmacology
article thumbnail

Exercise training in heart failure

Heart BMJ

Learning objectives To understand the importance of exercise and physical activity in the general management and well-being of people with heart failure (HF). To understand the key principles of exercise training prescription in people with HF. cross-ref type="bib".

article thumbnail

Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure

DAIC

FDA granted CardiAMP Cell Therapy a Breakthrough Device Designation for the treatment of ischemic heart failure. Leslie Miller, MD , trial investigator at the CHF Heart Function Clinic at BayCare Morton Plant Hospital in Clearwater, Florida and a member of the CardiAMP Heart Failure II Study Executive Steering Committee. “As

article thumbnail

New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy

DAIC

In about 70 percent of cases, patients with HCM experience obstruction to blood flow, which increases pressures in the heart and can lead to chest pain, shortness of breath and reduced exercise capacity. All participants were receiving background medical therapy and had reduced exercise capacity. Cytokinetics Inc.

article thumbnail

Real?world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population

European Journal of Heart Failure

gradient ≥30 mmHg at rest or ≥50 mmHg after Valsalva maneuver or exercise) despite pharmacological or non-pharmacological therapy. Results Pharmacological or non-pharmacological therapy resolved LVOTO in 1,044 (61.2%) of the 1,706 HOCM patients under active follow-up, whereas 662 patients (38.8%) had persistent LVOTO.

article thumbnail

National AFib Awareness Month: A Call to Action for Physicians Worldwide

ADN Center of Excellence

AFib is associated with a fivefold increased risk of stroke, and it is also linked to heart failure, chronic fatigue, and other serious health issues. From advances in pharmacological treatments to innovative procedures like catheter ablation, the landscape of AFib treatment is continually evolving.

AFIB 59
article thumbnail

American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

DAIC

The “Pharmacology Program” will cover hot topics in cardiovascular medicine that are key issues that pharmacists, as well as other health care team members, face in managing complex patients. 24 is guided by prominent clinicians and leaders, and focuses on important fundamentals in managing and treating heart conditions.

Education 105
article thumbnail

Expert Perspective: The Obesity Paradox with Salvatore Carbone, PhD

Cardiometabolic Health Congress

There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] Is the obesity paradox a real phenomenon?

Obesity 52